mRNA-2808

A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Near Add Your Location

Sorting 10 by

University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Not yet accepting
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
  • Not yet accepting
Winship Cancer Institute
Emory University
Atlanta, GA
  • Not yet accepting
Mount Sinai Hospital
Tisch Cancer Institute
New York, NY
  • Not yet accepting
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
  • Not yet accepting
Sarah Cannon Research Institute
TriStar Centennial Medical Center
Nashville, TN
  • Not yet accepting
Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.